Bryan brings 15 years of legal experience and 20 years of medical experience, as both a legal counselor and medical practitioner. Prior to joining Tarsus, Bryan was a Partner at Knobbe Martens LLP, where he focused on intellectual property protection, infringement studies and due diligence for financings and strategic transactions, specifically with respect to pharmaceutical, biotechnology and medical device companies. Bryan counseled clients from the pre-Series A stage through exit, including Tarsus, which has been one of his clients since shortly after it was founded. In addition to his law practice, Bryan has practiced inpatient internal medicine since 2002, most recently as a per diem hospitalist with Kaiser Permanente, caring for patients both on hospital wards and in the ICU.
Prior to joining Knobbe Martens, Bryan entered medical school after one undergraduate year, and received his medical degree with honors from the University of Hawaii John A. Burns School of Medicine in 1999. He completed an internal medicine residency in the UCLA-affiliated Cedars-Sinai Medical Center program in Los Angeles in 2002, and is board certified in Internal Medicine. Bryan earned his law degree from the University of California, Berkeley School of Law in 2005. In law school, he received three American Jurisprudence Awards, two Prosser Awards and the Barbee Fellowship, researching conflicts of interest of hospital institutional review boards, and was also a summer extern for the Honorable Ronald T.Y. Moon, Chief Justice of the Hawaii Supreme Court.
What is Bryan Wahl's net worth?
The estimated net worth of Bryan Wahl is at least $1.97 million as of March 18th, 2024. Dr. Wahl owns 40,951 shares of Tarsus Pharmaceuticals stock worth more than $1,969,334 as of March 15th. This net worth estimate does not reflect any other assets that Dr. Wahl may own. Additionally, Dr. Wahl receives a salary of $619,090.00 as General Counsel at Tarsus Pharmaceuticals. Learn More about Bryan Wahl's net worth.
How old is Bryan Wahl?
Dr. Wahl is currently 46 years old. There are 3 older executives and no younger executives at Tarsus Pharmaceuticals. The oldest executive at Tarsus Pharmaceuticals is Mr. Jeffrey S. Farrow, CFO & Chief Strategy Officer, who is 62 years old. Learn More on Bryan Wahl's age.
What is Bryan Wahl's salary?
As the General Counsel of Tarsus Pharmaceuticals, Inc., Dr. Wahl earns $619,090.00 per year. There are 2 executives that earn more than Dr. Wahl. The highest earning executive at Tarsus Pharmaceuticals is Dr. Seshadri Neervannan Ph.D., Chief Operating Officer, who commands a salary of $759,200.00 per year. Learn More on Bryan Wahl's salary.
How do I contact Bryan Wahl?
The corporate mailing address for Dr. Wahl and other Tarsus Pharmaceuticals executives is , , . Tarsus Pharmaceuticals can also be reached via phone at 949-409-9820 and via email at ir@tarsusrx.com. Learn More on Bryan Wahl's contact information.
Has Bryan Wahl been buying or selling shares of Tarsus Pharmaceuticals?
Bryan Wahl has not been actively trading shares of Tarsus Pharmaceuticals during the last quarter. Most recently, Bryan Wahl sold 4,436 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $30.60, for a transaction totalling $135,741.60. Following the completion of the sale, the general counsel now directly owns 40,951 shares of the company's stock, valued at $1,253,100.60. Learn More on Bryan Wahl's trading history.
Who are Tarsus Pharmaceuticals' active insiders?
Are insiders buying or selling shares of Tarsus Pharmaceuticals?
During the last year, insiders at the sold shares 4 times. They sold a total of 24,496 shares worth more than $749,577.60. The most recent insider tranaction occured on March, 18th when insider Aziz Mottiwala sold 4,766 shares worth more than $145,839.60. Insiders at Tarsus Pharmaceuticals own 8.3% of the company.
Learn More about insider trades at Tarsus Pharmaceuticals. Information on this page was last updated on 3/18/2024.
